# Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins

> **NCT03961763** · NA · COMPLETED · sponsor: **University of Chester** · enrollment: 44 (actual)

## Conditions studied

- Cardiovascular Diseases
- Hyperlipidemias
- Dyslipidemias

## Interventions

- **DIETARY_SUPPLEMENT:** EPA+DHA
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03961763
- **Lead sponsor:** University of Chester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2017-11-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2019-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961763, "Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03961763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*